February 3, 2011
February 3, 2011
Partner
WASHINGTON, DC - On January 25, 2011, the U.S. District Court for the Western District of Washington ruled in favor of Finnegan client Philips following a trial in Koninklijke Philips Electronics v. Cardiac Science Operating Co. The Court found that Cardiac Science’s patent application did not support the claims copied from Philips’s defibrillator patent and reversed the U.S. Patent and Trademark Office's decision against Philips in an interference.
With more than 375 intellectual property lawyers, Finnegan is one of the largest IP law firms in the world. From offices in Washington, DC; Atlanta, Georgia; Cambridge, Massachusetts; Palo Alto, California; Reston, Virginia; Brussels, Belgium; Shanghai, China; Taipei, Taiwan; and Tokyo, Japan, the firm practices all aspects of patent, trademark, copyright, and trade secret law, including counseling, prosecution, licensing, and litigation. Finnegan also represents clients on IP issues related to international trade, portfolio management, the Internet, e-commerce, government contracts, antitrust, and unfair competition. For additional information on the firm, please visit www.finnegan.com.
###
Press Release
August 18, 2026
Award/Ranking
Finnegan Named a Finalist for The American Lawyer 2026 Industry Awards
August 13, 2026
Award/Ranking
Finnegan Climbs Two Spots on The American Lawyer’s 2026: A-List Runners Up
August 12, 2026
Award/Ranking
Finnegan Receives Tier 1 Rankings from Managing IP; More than 30 Attorneys Named 2026 IP Stars
July 30, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.